This Startup Wants To Use Mini Robots To Treat Alzheimer’s

MMI is starting FDA-approved human trials for its tiny robot to use needles the size of eyelashes to help clear waste from the brains of Alzheimer’s patients.

Iranian Hackers Are Using Elon Musk’s Starlink To Stay Online

As the attacks continue, Iranians have turned to Space X’s satellite internet technology — including one of the country’s most notorious hacker crews, which is claiming retaliatory cyberattacks against the U.S.

Data Center Batteries Enter The Iron Age

This week’s Current Climate newsletter also looks at how Red Texas is turning green when it comes to energy and building up U.S. supply chains for a better electric grid

Google’s Data Center Buildout Could Top $1 Trillion

In an exclusive interview, Google’s new AI infrastructure chief says the tech giant has a “significant investment” planned. At current levels, Forbes projects it could be a very big number indeed.

European tech weekly recap: Over €2B invested in the tech ecosystem in the last week of February

Last week, we tracked more than 70 tech funding deals worth over €2 billion, and 5 exits, M&A transactions, rumours, and related news stories across Europe.Haberin devamını okumak için tıklayınız….

Warning: AI Is Coming For Your 401(k)

Stocks have low earnings yields and TIPS have good yields. Move money from stocks into bonds.

Aviation Carbon Study Suggests It’s Time To Scrap Business Class

New research shows that airlines could cut their carbon emissions by up to 50% just from reorganising plane seating. Is it time to cut business class completely?

The Startup Building An Operating System For Biotech AI

Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in this week’s edition of The Prototype.

This Looming Drug Development Gap Could Impact Patients’ Health

In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.

Novo Nordisk Inks A $2.1 Billion Deal To Develop Next Generation Obesity Pills

The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions of successors to Ozempic and Wegovy.